Cargando…
Longitudinal characterization of the IgM and IgG humoral response in symptomatic COVID-19 patients using the Abbott Architect
BACKGROUND: Antibody testing has recently emerged as an option to assist with determining exposure to SARS-CoV-2, the causative agent of COVID-19. Elucidation of the kinetics and duration of the humoral response is important for clinical management and interpreting results from serological surveys....
Autores principales: | Maine, Gabriel N., Lao, Kriselle Maris, Krishnan, Subhashree Mallika, Afolayan-Oloye, Olabisi, Fatemi, Seyedalireza, Kumar, Sandeep, VanHorn, Lindsay, Hurand, Ashley, Sykes, Elizabeth, Sun, Qian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590643/ https://www.ncbi.nlm.nih.gov/pubmed/33161369 http://dx.doi.org/10.1016/j.jcv.2020.104663 |
Ejemplares similares
-
Longitudinal evaluation of the Abbott ARCHITECT SARS-CoV-2 IgM and IgG assays in a pediatric population
por: Interiano, Cristina, et al.
Publicado: (2021) -
Clinical and analytical evaluation of the Abbott AdviseDx quantitative SARS-CoV-2 IgG assay and comparison with two other serological tests
por: Maine, Gabriel N., et al.
Publicado: (2022) -
A comparative evaluation between the Abbott Panbio™ COVID-19 IgG/IgM rapid test device and Abbott Architect™ SARS CoV-2 IgG assay
por: Batra, Rahul, et al.
Publicado: (2020) -
Dataset for longitudinal evaluation of the Abbott ARCHITECT SARS-CoV-2 IgM and IgG assays in a pediatric population divided by age
por: Interiano, Cristina, et al.
Publicado: (2021) -
Kinetics and performance of the Abbott architect SARS-CoV-2 IgG antibody assay
por: Hamilton, Fergus, et al.
Publicado: (2020)